Notices from NIH

  • Notice of Clarification on the Publication of the Final Rule on the Federal Policy for the Protections of Human Subjects (Common Rule)
    (NOT-OD-17-040) National Institutes of Health
  • Notice of NIAID’s Participation in RFA-OD-17-001 “Limited Competition: Research Resource for Human Organs and Tissues (U42)”
    (NOT-AI-17-008)
    National Institute of Allergy and Infectious Diseases
  • Notice of Clarification of 5-Year Limit of Postdoctoral Research Eligibility for PAR-16-434 “NIAID Career Transition Award (K22)”
    (NOT-AI-17-009)
    National Institute of Allergy and Infectious Diseases
  • Notice of Change of Key Dates for RFA-CA-17-005 “Cancer Immune Monitoring and Analysis Centers (CIMACs) (U24)”
    (NOT-CA-17-019)
    National Cancer Institute
  • Notice of Change of Key Dates for RFA-CA-17-006 “Cancer Immunologic Data Commons (CIDC) (U24)”
    (NOT-CA-17-020)
    National Cancer Institute
  • Notice of Change to RFA-CA-16-501 “Cancer Immunotherapy Trials Network (CITN)(UM1)” to Include a Pediatrics Immunotherapy Trials Element
    (NOT-CA-17-021)
    National Cancer Institute
  • Notice of Expiration of PAR-14-285 “Innovative Research in Cancer Nanotechnology (IRCN) (U01)”
    (NOT-CA-17-022)
    National Cancer Institute
  • Notice of Change to RFA-CA-17-006 “Cancer Immunologic Data Commons (CIDC) (U24)” to Include Collection and Analysis of Data for Specimens from Immunotherapy Trials for Pediatric Cancer Patients
    (NOT-CA-17-025)
    National Cancer Institute
  • Notice of Expiration of PAR-16-105 “Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)”
    (NOT-CA-17-027)
    National Cancer Institute
  • Notice of Add Letter of Intent Due Dates for RFA-EB-17-001 “Team-Based Design in Biomedical Engineering Education (R25)”
    (NOT-EB-17-001)
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Notice of NEI Participation in RFA-OD-17-001 “Limited Competition: Research Resource for Human Organs and Tissues (U42)”
    (NOT-EY-17-001)
    National Eye Institute
  • Centers for the Investigation of Factor VIII (FVIII) Immune Response in Patients with Hemophilia A (U54) FOA
    (NOT-HL-17-484)
    National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement (FOA): Implementation and Evaluation of New Health Information Technology Strategies for Collecting and Using Patient-Reported Outcome Measures
    (NOT-HS-17-006)
    Agency for Healthcare Research and Quality
  • Notice Announcing the Availability of Common Data Elements for Research Related to Early Psychosis
    (NOT-MH-17-009)
    National Institute of Mental Health
  • Notice of Participation by the Fogarty International Center in “Administrative Supplement for Research on Sex/Gender Influences (Admin Supp)” (PA-17-078)
    (NOT-TW-17-003)
    John E. Fogarty International Center
Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s